Kaku C, Starr T, Zhou P, Dugan H, Khalif xe9 P, Song G, et al. Evolution of antibody immunity following Omicron BA.1 breakthrough infection. Nat Commun. 2023;14:2751 pubmed publisher

Chernyshev M, Sakharkar M, Connor R, Dugan H, Sheward D, Rappazzo C, et al. Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages. Nat Commun. 2023;14:2249 pubmed publisher

Rappazzo C, Hsieh C, Rush S, Esterman E, Delgado T, Geoghegan J, et al. Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein. Immunity. 2022;55:1710-1724.e8 pubmed publisher

Mittler E, Wec A, Tynell J, Guardado Calvo P, Wigren Bystr xf6 m J, Polanco L, et al. Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses. Sci Transl Med. 2022;14:eabl5399 pubmed publisher

Woo M, Haag F, Nierhaus A, Jarczak D, Roedl K, Mayer C, et al. Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19. iScience. 2021;24:102752 pubmed publisher

Fels J, Maurer D, Herbert A, Wirchnianski A, Vergnolle O, Cross R, et al. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever. Cell. 2021;184:3486-3501.e21 pubmed publisher

Sakharkar M, Rappazzo C, Wieland Alter W, Hsieh C, Wrapp D, Esterman E, et al. Prolonged evolution of the human B cell response to SARS-CoV-2 infection. Sci Immunol. 2021;6: pubmed publisher